295 related articles for article (PubMed ID: 34420176)
21. PHBV/PLGA nanoparticles for enhanced delivery of 5-fluorouracil as promising treatment of colon cancer.
Handali S; Moghimipour E; Rezaei M; Ramezani Z; Dorkoosh FA
Pharm Dev Technol; 2020 Feb; 25(2):206-218. PubMed ID: 31648589
[TBL] [Abstract][Full Text] [Related]
22. Role of platelet-activating factor in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice.
Soares PM; Lima-Junior RC; Mota JM; Justino PF; Brito GA; Ribeiro RA; Cunha FQ; Souza MH
Cancer Chemother Pharmacol; 2011 Sep; 68(3):713-20. PubMed ID: 21153821
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-1 receptor antagonist reduced apoptosis and attenuated intestinal mucositis in a 5-fluorouracil chemotherapy model in mice.
Wu ZQ; Han XD; Wang Y; Yuan KL; Jin ZM; Di JZ; Yan J; Pan Y; Zhang P; Huang XY; Wang ZG; Zheng Q
Cancer Chemother Pharmacol; 2011 Jul; 68(1):87-96. PubMed ID: 20844880
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of CR3294, a new benzamidine derivative, in the prevention of 5-fluorouracil-induced gastrointestinal mucositis and diarrhea in mice.
Letari O; Booth C; Bonazzi A; Garofalo P; Makovec F; Rovati LC; Caselli G
Cancer Chemother Pharmacol; 2010 Oct; 66(5):819-27. PubMed ID: 20041326
[TBL] [Abstract][Full Text] [Related]
25. Anti-EGFR-mAb and 5-Fluorouracil Conjugated Polymeric Nanoparticles for Colorectal Cancer.
Bhattacharya S
Recent Pat Anticancer Drug Discov; 2021; 16(1):84-100. PubMed ID: 33349222
[TBL] [Abstract][Full Text] [Related]
26. Amelioration of 5-fluorouracil-induced intestinal mucositis by Streptococcus thermophilus ST4 in a mouse model.
Shen SR; Chen WJ; Chu HF; Wu SH; Wang YR; Shen TL
PLoS One; 2021; 16(7):e0253540. PubMed ID: 34310611
[TBL] [Abstract][Full Text] [Related]
27. Alleviation of 5-fluorouracil-induced intestinal mucositis in rats by vitamin E via targeting oxidative stress and inflammatory markers.
Al-Asmari AK; Khan AQ; Al-Asmari SA; Al-Rawi A; Al-Omani S
J Complement Integr Med; 2016 Dec; 13(4):377-385. PubMed ID: 27682716
[TBL] [Abstract][Full Text] [Related]
28. Saireito (TJ-114), a Japanese traditional herbal medicine, reduces 5-fluorouracil-induced intestinal mucositis in mice by inhibiting cytokine-mediated apoptosis in intestinal crypt cells.
Kato S; Hayashi S; Kitahara Y; Nagasawa K; Aono H; Shibata J; Utsumi D; Amagase K; Kadowaki M
PLoS One; 2015; 10(1):e0116213. PubMed ID: 25565296
[TBL] [Abstract][Full Text] [Related]
29. Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon.
Wu P; Zhou Q; Zhu H; Zhuang Y; Bao J
BMC Cancer; 2020 Apr; 20(1):354. PubMed ID: 32345258
[TBL] [Abstract][Full Text] [Related]
30. Apoptosis, Dysbiosis and Expression of Inflammatory Cytokines are Sequential Events in the Development of 5-Fluorouracil-Induced Intestinal Mucositis in Mice.
Hamouda N; Sano T; Oikawa Y; Ozaki T; Shimakawa M; Matsumoto K; Amagase K; Higuchi K; Kato S
Basic Clin Pharmacol Toxicol; 2017 Sep; 121(3):159-168. PubMed ID: 28374966
[TBL] [Abstract][Full Text] [Related]
31. Regulatory role of Lactobacillus acidophilus on inflammation and gastric dysmotility in intestinal mucositis induced by 5-fluorouracil in mice.
Justino PF; Melo LF; Nogueira AF; Morais CM; Mendes WO; Franco AX; Souza EP; Ribeiro RA; Souza MH; Soares PM
Cancer Chemother Pharmacol; 2015 Mar; 75(3):559-67. PubMed ID: 25572363
[TBL] [Abstract][Full Text] [Related]
32. A polyphenol-rich açaí seed extract protects against 5-fluorouracil-induced intestinal mucositis in mice through the TLR-4/MyD88/PI3K/mTOR/NF-κBp65 signaling pathway.
Monteiro CEDS; de Cerqueira Fiorio B; Silva FGO; de Fathima Felipe de Souza M; Franco ÁX; Lima MAS; Sales TMAL; Mendes TS; Havt A; Barbosa ALR; Resende ÂC; de Moura RS; de Souza MHLP; Soares PMG
Nutr Res; 2024 May; 125():1-15. PubMed ID: 38428258
[TBL] [Abstract][Full Text] [Related]
33. Neutrophil elastase inhibitor (MPH-966) improves intestinal mucosal damage and gut microbiota in a mouse model of 5-fluorouracil-induced intestinal mucositis.
Chen KJ; Chen YL; Ueng SH; Hwang TL; Kuo LM; Hsieh PW
Biomed Pharmacother; 2021 Feb; 134():111152. PubMed ID: 33373916
[TBL] [Abstract][Full Text] [Related]
34. Orally administered salecan ameliorates methotrexate-induced intestinal mucositis in mice.
Gao Y; Sun Q; Yang X; Lu W; Zhao Y; Ge W; Yang Y; Xu X; Zhang J
Cancer Chemother Pharmacol; 2019 Jul; 84(1):105-116. PubMed ID: 31069451
[TBL] [Abstract][Full Text] [Related]
35. Effects of acid antisecretory drugs on mucus barrier of the rat against 5-fluorouracil-induced gastrointestinal mucositis.
Saegusa Y; Ichikawa T; Iwai T; Goso Y; Ikezawa T; Nakano M; Shikama N; Saigenji K; Ishihara K
Scand J Gastroenterol; 2008; 43(5):531-7. PubMed ID: 18415744
[TBL] [Abstract][Full Text] [Related]
36. Oral administration of cystine and theanine attenuates 5-fluorouracil-induced intestinal mucositis and diarrhea by suppressing both glutathione level decrease and ROS production in the small intestine of mucositis mouse model.
Yoneda J; Nishikawa S; Kurihara S
BMC Cancer; 2021 Dec; 21(1):1343. PubMed ID: 34922485
[TBL] [Abstract][Full Text] [Related]
37. May cannabinoids prevent the development of chemotherapy-induced diarrhea and intestinal mucositis? Experimental study in the rat.
Abalo R; Uranga JA; Pérez-García I; de Andrés R; Girón R; Vera G; López-Pérez AE; Martín-Fontelles MI
Neurogastroenterol Motil; 2017 Mar; 29(3):. PubMed ID: 27686064
[TBL] [Abstract][Full Text] [Related]
38. Potential role of the NADPH oxidase NOX1 in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice.
Yasuda M; Kato S; Yamanaka N; Iimori M; Utsumi D; Kitahara Y; Iwata K; Matsuno K; Amagase K; Yabe-Nishimura C; Takeuchi K
Am J Physiol Gastrointest Liver Physiol; 2012 May; 302(10):G1133-42. PubMed ID: 22403796
[TBL] [Abstract][Full Text] [Related]
39. Losartan improves intestinal mucositis induced by 5-fluorouracil in mice.
Oliveira MMB; de Araújo AA; Ribeiro SB; de Sales Mota PCM; Marques VB; da Silva Martins Rebouças C; Figueiredo JG; Barra PB; de Castro Brito GA; de Carvalho Leitão RF; Guerra GCB; de Medeiros CACX
Sci Rep; 2021 Dec; 11(1):23241. PubMed ID: 34853351
[TBL] [Abstract][Full Text] [Related]
40. CXCL9 attenuated chemotherapy-induced intestinal mucositis by inhibiting proliferation and reducing apoptosis.
Han X; Wu Z; Di J; Pan Y; Zhang H; Du Y; Cheng Z; Jin Z; Wang Z; Zheng Q; Zhang P; Wang Y
Biomed Pharmacother; 2011 Dec; 65(8):547-54. PubMed ID: 21775092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
